OBIO

2.565

3.57% -0.095

Handel nachbörslich: 2.57 0.005 +0.19%

Orchestra Biomed Holdings Inc (OBIO)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$2.66

Offen:

$2.67

24-Stunden-Volumen:

237.11K

Relative Volume:

0.78

Marktkapitalisierung:

$99.12M

Einnahmen:

$2.76M

Nettoeinkommen (Verlust:

$-49.12M

KGV:

-1.71

EPS:

-1.5

Netto-Cashflow:

$-46.21M

1W Leistung:

-5.35%

1M Leistung:

-12.16%

6M Leistung:

-54.76%

1J Leistung:

-57.67%

1-Tages-Spanne:

$2.56

$2.68

1-Wochen-Bereich:

$2.50

$2.75

52-Wochen-Spanne:

$2.37

$7.04

Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile

Firmenname

Orchestra Biomed Holdings Inc

Sektor

Healthcare (1157)

Branche

Biotechnology (645)

Telefon

646-343-9298

Adresse

150 UNION SQUARE DRIVE, NEW HOPE

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

OBIO's Discussions on Twitter

Vergleichen Sie OBIO mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
OBIO Orchestra Biomed Holdings Inc	2.565	143.51M	2.76M	-49.12M	-46.21M	-1.50
VRTX Vertex Pharmaceuticals Inc	392.79	100.07B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	580.41	59.99B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	448.91	58.03B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	653.83	39.93B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	321.36	36.82B	3.81B	-644.79M	-669.77M	-6.24

Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-03-20	Eingeleitet	BTIG Research	Buy
2025-01-02	Eingeleitet	Barclays	Overweight
2024-08-22	Eingeleitet	H.C. Wainwright	Buy
2024-07-25	Eingeleitet	B. Riley Securities	Buy
2024-01-19	Eingeleitet	Jefferies	Buy
2023-02-24	Eingeleitet	Piper Sandler	Overweight
2023-02-07	Eingeleitet	Chardan Capital Markets	Buy

Alle ansehen

Orchestra Biomed Holdings Inc Aktie (OBIO) Neueste Nachrichten

Aug 16, 2025

Reversal indicators forming on Orchestra BioMed Holdings Inc. stock2025 Valuation Update & Long Hold Capital Preservation Tips - Newser

Aug 16, 2025

Orchestra BioMed Secures $111M to Advance Late-Stage Cardiac Therapies, Hits Multiple FDA Milestones - MSN

Aug 16, 2025

Will a bounce in Orchestra BioMed Holdings Inc. offer an exitQuarterly Trade Summary & Fast Moving Stock Watchlists - Newser

Aug 16, 2025

Understanding Orchestra BioMed Holdings Inc.’s price movementJuly 2025 Gainers & Weekly High Return Forecasts - Newser

Aug 16, 2025

Advanced analytics toolkit walkthrough for Orchestra BioMed Holdings Inc.July 2025 Short Interest & Risk Controlled Daily Plans - Newser

Aug 16, 2025

Best data tools to analyze Orchestra BioMed Holdings Inc. stock2025 Support & Resistance & Long-Term Safe Return Strategies - Newser

Aug 16, 2025

Will Orchestra BioMed Holdings Inc. continue its uptrendIndex Update & Long-Term Growth Plans - Newser

Aug 16, 2025

Can Orchestra BioMed Holdings Inc. hit a new high this monthDay Trade & AI Enhanced Trading Signals - Newser

Aug 16, 2025

What the charts say about Orchestra BioMed Holdings Inc. today2025 Volume Leaders & High Conviction Investment Ideas - Newser

Aug 16, 2025

Long term hold vs stop loss in Orchestra BioMed Holdings Inc.Trade Volume Report & Verified Entry Point Signals - Newser

Aug 16, 2025

Is Orchestra BioMed Holdings Inc. stock bottoming outWeekly Trend Report & AI Enhanced Execution Alerts - Newser

Aug 16, 2025

Is a relief rally coming for Orchestra BioMed Holdings Inc. holders2025 Technical Overview & Real-Time Stock Movement Alerts - Newser

Aug 16, 2025

Aug 15, 2025

What data driven models say about Orchestra BioMed Holdings Inc.’s futureGlobal Markets & Detailed Earnings Play Alerts - Newser

Aug 15, 2025

Will Orchestra BioMed Holdings Inc. see short term momentumEarnings Summary Report & High Yield Equity Trading Tips - Newser

Aug 15, 2025

Does Orchestra BioMed Holdings Inc. fit your quant trading modelJobs Report & AI Forecast Swing Trade Picks - Newser

Aug 15, 2025

How to integrate Orchestra BioMed Holdings Inc. into portfolio analysis toolsIPO Watch & Reliable Breakout Forecasts - Newser

Aug 15, 2025

Why Orchestra BioMed Holdings Inc. is moving today2025 Valuation Update & Fast Exit/Entry Strategy Plans - Newser

Aug 15, 2025

How cyclical is Orchestra BioMed Holdings Inc.’s revenue streamBreakout Watch & Growth Focused Entry Reports - mustnews.co.kr

Aug 15, 2025

Real time scanner hits for Orchestra BioMed Holdings Inc. explainedTrade Risk Assessment & Daily Volume Surge Trade Alerts - Newser

Aug 15, 2025

Why Orchestra BioMed Holdings Inc. stock attracts strong analyst attentionMarket Activity Recap & Risk Controlled Stock Pick Alerts - Newser

Aug 15, 2025

Aug 14, 2025

Should you wait for a breakout in Orchestra BioMed Holdings Inc.2025 Macro Impact & Daily Entry Point Trade Alerts - Newser

Aug 14, 2025

FDA Greenlights Broader Patient Access for AVIM Therapy Trial in Pacemaker Patients - MSN

Aug 14, 2025

Orchestra BioMed Announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic Dysfunction - The Manila Times

Aug 14, 2025

Orchestra BioMed Announces Publication of AVIM Therapy - GlobeNewswire

Aug 14, 2025

Novel Heart Therapy Shows Dual Benefits: Reduces Blood Pressure While Improving Cardiac Function - Stock Titan

Aug 14, 2025

Signal strength of Orchestra BioMed Holdings Inc. stock in tech scannersWeekly Investment Report & Community Trade Idea Sharing - Newser

Aug 14, 2025

Aug 13, 2025

Detecting support and resistance levels for Orchestra BioMed Holdings Inc.Weekly Trend Report & Accurate Intraday Trading Signals - Newser

Aug 13, 2025